Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor
- PMID: 1334423
- DOI: 10.1002/chir.530040703
Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor
Abstract
The ability of two enantiomeric fluoro-analogues of D-myo-inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] to mobilize intracellular Ca2+ stores in SH-SY5Y neuroblastoma cells has been investigated. (-)-D-2,2-difluoro-2-deoxy-myo-Ins(1,4,5)P3 [D-2,2-F2-Ins(1,4,5)P3] was a full agonist [EC50 0.21 microM] and slightly less potent than D-Ins(1,4,5)P3 [EC50 0.13 microM]. (+)-L-2,2-F2Ins(1,4,5)P3 was a very poor agonist, confirming the stereospecificity of the Ins(1,4,5)P3 receptor. D-2,2-F2-Ins(1,4,5)P3 mobilized Ca2+ with broadly similar kinetics to Ins(1,4,5)P3 and was a substrate for Ins(1,4,5)P3 3-kinase inhibiting Ins(1,4,5)P3 phosphorylation (apparent Ki = 10.2 microM) but was recognised less well than Ins(1,4,5)P3. L-2,2-F2-Ins(1,4,5)P3 was a potent competitive inhibitor of 3-kinase (Ki = 11.9 microM). Whereas D-2,2-F2-Ins(1,4,5)P3 was a good substrate for Ins(1,4,5)P3 5-phosphatase, L-2,2-F2Ins(1,4,5)P3 was a relatively potent inhibitor (Ki = 19.0 microM).
Similar articles
-
Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase.FEBS Lett. 1990 Dec 10;276(1-2):91-4. doi: 10.1016/0014-5793(90)80515-k. FEBS Lett. 1990. PMID: 2176165
-
Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.Mol Pharmacol. 1993 Apr;43(4):499-503. Mol Pharmacol. 1993. PMID: 8386304
-
Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.FEBS Lett. 1991 Jan 28;278(2):252-6. doi: 10.1016/0014-5793(91)80128-p. FEBS Lett. 1991. PMID: 1846823
-
The families of kinases removing the Ca2+ releasing second messenger Ins(1,4,5)P3.Curr Mol Med. 2004 May;4(3):277-90. doi: 10.2174/1566524043360726. Curr Mol Med. 2004. PMID: 15101685 Review.
-
New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor.Trends Pharmacol Sci. 1998 Nov;19(11):467-75. doi: 10.1016/s0165-6147(98)01260-7. Trends Pharmacol Sci. 1998. PMID: 9850611 Review.
Cited by
-
Design and Synthesis of an Inositol Phosphate Analog Based on Computational Docking Studies.Tetrahedron. 2014 Jan 28;70(4):984-990. doi: 10.1016/j.tet.2013.11.092. Tetrahedron. 2014. PMID: 25110363 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous